Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Thoracic and Cardiovascular Surgery

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jtcvs.2010.02.039PMID 20416887
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small cell lung cancer: a phase III randomized controlled trial

  2010cited by this paper
• Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

  2009cited by this paper
• Risks of neoadjuvant chemotherapy and radiation therapy.

  2008cited by this paper
• Early surgical results after pneumonectomy for non-small cell lung cancer are not affected by preoperative radiotherapy and chemotherapy.

  2008cited by this paper
• Induction chemotherapy does not increase the operative risk of pneumonectomy!

  2007cited by this paper
• Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.

  2007cited by this paper
• Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.

  2006cited by this paper
• ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer.

  2006cited by this paper
• Morbidity and mortality in the surgery arm of EORTC 08941 trial

  2005cited by this paper
• Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection.

  2005cited by this paper
• Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.

  2004cited by this paper
• Surgery after multimodality treatment for non-small-cell lung cancer.

  2004cited by this paper
• Surgeon volume and operative mortality in the United States.

  2003cited by this paper
• Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer.

  2003cited by this paper
• Risk factors for early mortality and major complications following pneumonectomy for non-small cell carcinoma of the lung.

  2002cited by this paper
• Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients.

  2002cited by this paper
• Pneumonectomy for non-small cell lung cancer: predictors of operative mortality and survival.

  2001cited by this paper
• Postoperative complications in relation with induction therapy for lung cancer.

  2001cited by this paper
• Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy.

  2001cited by this paper
• The new World Health Organization classification of lung tumours

  2001cited by this paper
• Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.

  1998cited by this paper
• A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

  1994cited by this paper
• A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

  1994cited by this paper
• Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non‐small cell lung cancer

  1994cited by this paper
• Postoperative complications after combined neoadjuvant treatment of lung cancer.

  1993cited by this paper
• Surgical treatment for higher stage non-small cell lung cancer.

  1992cited by this paper

• Treatment of inoperable stage III non-small cell lung cancer

  2025cites this paper
• Current perspective on resectability in stage III locally advanced NSCLC - The thoracic surgeons' view.

  2025cites this paper
• A retrospective analysis of neoadjuvant chemotherapy in pneumonectomy for locally advanced central non–small cell lung cancer

  2025cites this paper
• Reduction in surgical scope after neoadjuvant chemotherapy and immunotherapy for non-small cell lung cancer

  2025cites this paper
• Pathologic Complete Response Predicts Long‐Term Survival Following Neoadjuvant Induction Chemotherapy and Chemo‐Radiotherapy in Stage‐III Non‐Small Cell Lung Cancer

  2025cites this paper
• Updated review of perioperative treatment for non-small-cell lung cancer in the new era of immune checkpoint inhibitors: past, present, and future.

  2024cites this paper
• Enhancing Patient Selection in Stage IIIA-IIIB NSCLC: Invasive Lymph Node Restaging after Neoadjuvant Therapy

  2024cites this paper
• Salvage extended surgery after immune-checkpoint inhibitor treatment for advanced non-small cell lung cancer

  2024cites this paper
• Surgery patterns and survival of T4N2 non-small cell lung cancer – A population-based analysis

  2024cites this paper
• Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung Cancer

  2023cites this paper
• Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options

  2023cites this paper
• Pneumonectomy for Primary Lung Tumors and Pulmonary Metastases: A Comprehensive Study of Postoperative Morbidity, Early Mortality, and Preoperative Clinical Prognostic Factors

  2023cites this paper
• The oncologic efficacy of extended resections for lung cancer

  2023cites this paper
• Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms

  2023cites this paper
• Patient Selection for Local Aggressive Treatment in Oligometastatic Non-Small Cell Lung Cancer

  2021cites this paper
• Safe pneumonectomy for locally advanced lung cancer after induction therapy

  2021cites this paper
• Major Pulmonary Resection After Neoadjuvant Therapy in Potentially Resectable Stage IIIA/B Non-Small Cell Lung Carcinoma: R0 or No R0

  2021cites this paper
• Evaluation of prognostic factors in lung cancers with surgical complete response after induction treatment

  2021cites this paper
• Advances in multimodal treatment for stage IIIA-N2 non-small cell lung cancer

  2021cites this paper
• Oncological outcomes of unsuspected pN2 in patients with non-small-cell lung cancer: a systematic review and meta-analysis

  2021cites this paper
• Major pulmonary resection after neoadjuvant chemotherapy or chemoradiation in potentially resectable stage III non-small cell lung carcinoma

  2021cites this paper
• Pneumonectomy for lung cancer in the elderly: lessons learned from a multicenter study

  2021cites this paper
• Cardiopulmonary bypass for resection of pancoast tumor with mediastinal extension and involvement of right bronchial branch: A case report

  2021cites this paper
• Oncological outcomes of unsuspected pN2 in patients with non-small-cell lung cancer: a systematic review and meta-analysis.

  2021cites this paper
• Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists

  2021cites this paper
• Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improve.

  2020cites this paper
• The analysis of prognosis factor in patients with non-small cell lung cancer receiving pneumonectomy

  2020cites this paper
• Development of a nomogram for predicting the operative mortality of patients who underwent pneumonectomy for lung cancer: a population-based analysis

  2020influential citation
• Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?

  2020cites this paper
• Heterogeneity of stage IIIA non-small cell lung cancer—different tumours, different nodal status, different treatment, different prognosis: a narrative review

  2020cites this paper
• Primary pneumonectomy, pneumonectomy after induction therapy, and salvage pneumonectomy: a comparison of surgical and prognostic outcomes

  2020cites this paper
• Pneumonectomie

  2020cites this paper
• Surgery as a Component of Multimodality Care for Known Stage IIIA-N2 Non-small Cell Lung Cancer

  2020cites this paper
• Feasibility and prognostic benefit of induction chemoradiotherapy followed by surgery in patients with locally advanced non-small cell lung cancer

  2020cites this paper
• Keys to successful induction chemoradiotherapy followed by surgery for stage III/N2 non-small cell lung cancer

  2019cites this paper
• Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients

  2019cites this paper
• Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?

  2019cites this paper
• Ergebnisse der N1- und N2-Chirurgie beim nichtkleinzelligen Lungenkarzinom

  2019cites this paper
• Bronchus anastomosis healing depending on type of neoadjuvant therapy.

  2019cites this paper
• Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)

  2019cites this paper
• Surgical Management of IIIA/N2 Non-Small Cell Lung Cancer: A Systematic Review

  2019cites this paper
• Pneumonectomy with Esophageal Resection and Reconstruction for Squamous Cell Carcinoma of the Lung as Salvage Surgery

  2018cites this paper
• Response to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- ain't no mountain high enough…. to keep me getting to you by Jeremic Branislav.

  2018cites this paper
• Surgical outcomes and complications of pneumonectomy after induction therapy for non-small cell lung cancer

  2018cites this paper
• Neoadjuvant and consolidation immuno-oncology therapy in stage III non-small cell lung cancer.

  2018cites this paper
• Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer

  2018cites this paper
• Definitive radiochemotherapy versus surgery within multimodality treatment in stage III non-small cell lung cancer (NSCLC) - a cumulative meta-analysis of the randomized evidence

  2017cites this paper
• Is pneumonectomy a justified procedure in patients with persistent N2 nonsmall cell lung cancer disease following induction therapy.

  2017cites this paper
• Pneumonectomy is safe and effective for non-small cell lung cancer following induction therapy.

  2017cites this paper
• Advances in the use of surgery and multimodality treatment for N2 non-small cell lung cancer

  2017cites this paper
• Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer

  2017cites this paper
• Clinical benefit of neoadjuvant chemoradiotherapy for the avoidance of pneumonectomy; assessment in 12 consecutive centrally located non-small cell lung cancers

  2017cites this paper
• Venous thromboembolism prophylaxis in cancer patients — guidelines focus on surgical patients

  2017cites this paper
• Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer†

  2017cites this paper
• Role of surgery in N2 NSCLC: pros.

  2016cites this paper
• Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment

  2016cites this paper
• Surgery for Stage IIIA Non-Small-cell Lung Cancer: Lack of Predictive and Prognostic Factors Identifying Any Subgroup of Patients Benefiting From It.

  2016cites this paper
• Does Neoadjuvant Chemotherapy Have a Role in Stage IIIA Lung Cancer Requiring Pneumonectomy?

  2016cites this paper
• Lung cancer

  2016cites this paper
• Population‐Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013

  2016cites this paper
• PRİMER AKCİĞER KANSERİNDE NEOADJUVAN TEDAVİ UYGULANMIŞ HASTALARDA AKCİĞER REZEKSİYONLARI: İLK 90 OLGUNUN GÜNCEL BİLGİLERİMİZLE GÖZDEN GEÇİRİLMESİ

  2016cites this paper
• Management of Stage IIIA (N2) Non-Small Cell Lung Cancer.

  2016cites this paper
• Stage III Non-small Cell Lung Cancer

  2016cites this paper
• Long-term survival results of non-small cell lung cancer patients with complete pathological response after neoadjuvant therapy

  2016cites this paper
• radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment

  2016cites this paper
• Postoperative morbidity and mortality after pneumonectomy: a 30-year experience of 2064 consecutive patients.

  2015cites this paper
• 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.

  2015cites this paper
• Venous thromboembolism and lung cancer: a review

  2015cites this paper
• Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomy.

  2015cites this paper
• Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection

  2015cites this paper
• Pneumonectomy for lung cancer: contemporary national early morbidity and mortality outcomes.

  2015cites this paper
• Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer.

  2015cites this paper
• Multimodality treatment with surgery for locally advanced non-small-cell lung cancer with n2 disease: a review article.

  2015cites this paper
• Morbidity and mortality after major pulmonary resections in patients with locally advanced stage IIIA non-small cell lung carcinoma who underwent induction therapy.

  2015cites this paper
• Induction Therapy for Mesothelioma.

  2015cites this paper
• Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).

  2015cites this paper
• Approaches in patients with locally advanced NSCLC : a surgeon's perspective

  2015cites this paper
• Multidisciplinary therapy of stage IIIA non-small-cell lung cancer: long-term outcome of chemoradiation with or without surgery.

  2014cites this paper
• National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer

  2014cites this paper
• Current status of induction treatment for N2-Stage III non-small cell lung cancer

  2014cites this paper
• NCCN Guidelines Version 1.2015 Panel Members Non-Small Cell Lung Cancer

  2014cites this paper
• Pneumonectomy for node-positive non-small cell lung cancer: can it be a treatment option for N2 disease?

  2014cites this paper
• Pneumonectomy After Induction Therapy for Non-small Cell Lung Cancer

  2014cites this paper
• Place de la chirurgie dans le traitement des cancers localement avancés

  2014cites this paper
• Neoadjuvant chemotherapy is a risk factor for bronchopleural fistula after pneumonectomy for non-small cell lung cancer

  2014cites this paper
• Non-small cell lung cancer, version 1.2015.

  2014cites this paper
• NCCN Non – Small Cell Lung Cancer , Version 1 . 2015 Clinical Practice Guidelines in Oncology

  2014cites this paper
• Pneumonectomy for stage IIIA NSCLC: a chance, not a calamity.

  2014cites this paper
• Survival after Pneumonectomy for Stage III Non-small Cell Lung Cancer.

  2014cites this paper
• Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer.

  2014cites this paper
• Pneumonectomy for Non-Small Cell Lung Cancer: Predictors of Early Mortality and Morbidity

  2014cites this paper
• Prevalence of venous thromboembolism in elective thoracic surgery.

  2013cites this paper
• Prevalence of venous thromboembolism in elective thoracic surgery.

  2013cites this paper
• The role of chemotherapy in the management of stage IIIA non-small cell lung cancer.

  2013cites this paper
• Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer: Markedly higher rate of pathologic complete remissions than with conventional fractionation.

  2013cites this paper
• Does pneumonectomy have a role in the treatment of stage IIIA non-small cell lung cancer?

  2013cites this paper
• [National consensus of diagnosis and treatment of non-small cell lung cancer].

  2013cites this paper
• Role of induction therapy: surgical resection of non-small cell lung cancer after induction therapy.

  2013cites this paper
• Routine intraoperative frozen section analysis of bronchial margins is of limited utility in lung cancer resection.

  2013cites this paper
• Long-Term Outcome after En Bloc Resection of Non–Small-Cell Lung Cancer Invading the Pulmonary Sulcus and Spine

  2013cites this paper